Skip to Content
Search Menu

Update from EULAR with new data for spondylarthropathies

Lars Erik Kristensen, specialist in internal medicine and rheumatology, presents in this MEDtalk new studies from EULAR on spondylarthropathies – from diagnostic challenges, comorbidity and mortality to the importance of the microbiome and the risk of COVID-19.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Asiaan liittyvä sisältö

Increased Antibiotic Use Prior to Onset of Inflammatory Arthritis

/ Maja Skov Kragsnæs / Torkell Ellingsen
AntibioticsGut microbiotaPsoriatic arthritisRheumatoid arthritisSpA

New Safety Checklist for Antirheumatic Drugs

/ Lykke Skaarup / Tue Kragstrup
JAK-inhibitorsPsoriatic arthritisRheumatoid arthritisSpA
Nora Borislavova Vladimirova

High Prevalence of Axial Spondyloarthritis in Inflammatory Bowel Disease Patients

/ Nora Vladimirova
IBDSpA Play the Video 07:43
Astrid Jensen Damgaard

Measurement of Fatigue in Patients with Spondyloarthritis: Validation of the Danish Versions of the BRAFs

/ Astrid Jensen Damgaard
Rheumatoid arthritisSpA Play the Video 06:41

SCR 2023 – Four Days of Inspiring Data and Interdisciplinary Dialogue

/ Jan Andreasen
EULAR23SCR23SpA
Désirée Van Der Heijde

BE MOBILE 2: Bimekizumab in patients with active ankylosing spondylitis

/ Désirée van der Heijde
EULAR22SpA Play the Video 6:26

Ovatko magneettikuvantaminen ja uudet luokittelukriteerit lisänneet aksiaalisen spondylartriitin ilmaantuvuutta ja lyhentäneet diagnostista viivettä?

/ Heikki Julkunen
Back painSpA

Obese patients with axSpA have greater disease activity and spinal stiffness

/ Marco Garrido-Cumbrera
EULAR21 Play the Video 8:27

Differential diagnoses in suspected axial SpA

/ Mikkel Østergaard
EULAR21 Play the Video 16:19
Back to top